MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale

AI SummaryClose X

MindMaze Therapeutics Holding SA announced the appointment of Zach Henderson, a veteran in HealthTech with over 30 years of experience and a proven track record in scaling healthcare technology platforms and driving recurring revenue growth, as its new Chief Executive Officer. Henderson's appointment is intended to accelerate the company's global commercial scale, with a specific focus on expanding its U.S. market presence and the delivery of scalable, AI-driven neurorestorative care. This strategic move aims to address the significant supply-demand gap in neurological care by shifting treatment from episodic, clinic-bound sessions to continuous, data-driven neurorestoration accessible in both clinical and home settings. Alexandre Capet will continue to serve as Chief Operating and Strategy Officer.

Disclaimer*

UK 100

Latest directors dealings